Corresponding Author: Giuseppe Querques, MD, PhD, Department of Ophthalmology, Hospital San Raffaele, University Vita Salute San Raffaele, Via Olgettina 60, Milan 20132, Italy (giuseppe.querques@hotmail.it).
Published Online: September 19, 2019. doi:10.1001/jamaophthalmol.2019.3643
Conflict of Interest Disclosures: Dr Querques reports personal fees from Alimera Sciences, Allergan, Bayer, KBH, LumiThera, Novartis, Zeiss, Topcon, Roche, Heidelberg Pharma, SIFI, Bausch + Lomb, Sooft-Fidia, and Sandoz outside the submitted work. No other disclosures were reported.
Additional Contributions: We thank the patient for granting permission to publish this information.
4.Bral
NOG, Marinkovic
M, Leroy
BP, Hoornaert
K, van Lint
M, ten Tusscher
MPM. Do not turn a blind eye to alkyl nitrite (poppers)!
Acta Ophthalmol. 2016;94(1):e82-e83. doi:
10.1111/aos.12753PubMedGoogle Scholar 7.Davies
AJ, Borschmann
R, Kelly
SP, Ramsey
J, Ferris
J, Winstock
AR. The prevalence of visual symptoms in poppers users: a global survey.
BMJ Open Ophthalmol. 2017;1(1):e000015. doi:
10.1136/bmjophth-2016-000015Google Scholar 9.Prascina
F, Querques
G, Russo
V, Iaculli
C, Noci
ND. Morphologic and functional changes in solar retinopathy: a study by optical coherence tomography and fundus-related perimetry.
Retin Cases Brief Rep. 2007;1(4):267-270. doi:
10.1097/01.iae.0000243418.63583.b2PubMedGoogle Scholar 10.Mainster
MA, Turner
PL. Photic retinal injuries: mechanisms, hazards, and prevention. In: Ryan
SJ, Sadda
WR, Hinton
DR,
et al, eds. Retina. 5th ed. Philadelphia, PA: Saunders;2012.